Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)180.00
  • Today's Change5.85 / 3.36%
  • Shares traded223.68k
  • 1 Year change+162.54%
  • Beta0.6148
Data delayed at least 15 minutes, as of Nov 22 2024 16:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue5,2525,5175,777
OPERATING EXPENSES
Cost of revenue total1,7071,6741,438
Selling, general and admin. expenses, total1,7981,7371,556
Depreciation/amortization------
Unusual expense(income)(90)9636
Other operating expenses, total(397)(243)(166)
Total operating expense4,6484,9344,493
Operating income6045831,284
Other, net(12)(5)(3)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes4415111,226
Provision for income taxes9891170
Net income after taxes3434201,056
Minority interest000
Net income before extra. Items3434201,056
Total extraordinary items0(2)3.00
Net income3434181,059
Inc.avail. to common excl. extra. Items3434201,055
Inc.avail. to common incl. extra. Items3434181,058
EPS RECONCILIATION
Basic/primary weighted average shares190190189
Basic/primary eps excl. extra items1.812.215.58
Basic/primary eps incl. extra items1.812.205.60
Dilution adjustment------
Diluted weighted average shares195195194
Diluted eps excl. extra items1.762.165.43
Diluted eps incl. extra items1.762.155.45
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.950.930.91
Gross dividend - common stock252247240
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental1447145
SUPPLEMENTAL INCOME
Depreciation, supplemental158148135
Total special items(90)9636
NORMALISED INCOME
Normalized income before taxes3516071,262
Effect of special items on income taxes(20)174.99
Income tax excluding impact of special items78108175
Normalized income after tax2734991,087
Normalized income avail. to common2734991,086
Basic normalized EPS1.442.635.75
Diluted normalized EPS1.402.565.59
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.